These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 22765891

  • 21. In vitro antibacterial activity of echinomycin and a novel analogue, YK2000, against vancomycin-resistant enterococci.
    Kim JB, Lee GS, Kim YB, Kim SK, Kim YH.
    Int J Antimicrob Agents; 2004 Dec; 24(6):613-5. PubMed ID: 15555887
    [Abstract] [Full Text] [Related]

  • 22. Thiosemicarbazones active against Clostridium difficile.
    Costello C, Karpanen T, Lambert PA, Mistry P, Parker KJ, Rathbone DL, Ren J, Wheeldon L, Worthington T.
    Bioorg Med Chem Lett; 2008 Mar 01; 18(5):1708-11. PubMed ID: 18243694
    [Abstract] [Full Text] [Related]

  • 23. Solid- and solution-phase synthesis of vancomycin and vancomycin analogues with activity against vancomycin-resistant bacteria.
    Nicolaou KC, Cho SY, Hughes R, Winssinger N, Smethurst C, Labischinski H, Endermann R.
    Chemistry; 2001 Sep 03; 7(17):3798-823. PubMed ID: 11575782
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Structure-activity relationships in the series of eremomycin carboxamides.
    Miroshnikova OV, Printsevskaya SS, Olsufyeva EN, Pavlov AY, Nilius A, Hensey-Rudloff D, Preobrazhenskaya MN.
    J Antibiot (Tokyo); 2000 Mar 03; 53(3):286-93. PubMed ID: 10819300
    [Abstract] [Full Text] [Related]

  • 32. [Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002].
    Pituch H, Obuch-Woszczatyński P, Glinka D, Łazińska B, Meisel-Mikołajczyk F, Łuczak M.
    Med Dosw Mikrobiol; 2003 Mar 03; 55(3):253-8. PubMed ID: 14702667
    [Abstract] [Full Text] [Related]

  • 33. Synthesis and antibacterial activity of N4-mono alkyl derivatives of novel glycopeptide LYV07ww01.
    Shao C, Zhou W, Zhang S, Wei W, Ruan L, Jin Y, Sun X, Huang Y.
    Bioorg Med Chem Lett; 2011 Nov 15; 21(22):6732-8. PubMed ID: 21978682
    [Abstract] [Full Text] [Related]

  • 34. In vitro effect of metronidazole and vancomycin in combination on Clostridium difficile.
    Hames A, Perry JD, Gould FK.
    J Antimicrob Chemother; 2009 May 15; 63(5):1076. PubMed ID: 19240074
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model.
    Baines SD, O'Connor R, Saxton K, Freeman J, Wilcox MH.
    J Antimicrob Chemother; 2009 Mar 15; 63(3):520-5. PubMed ID: 19112083
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Vancomycin analogues containing monosaccharides exhibit improved antibiotic activity: a combined one-pot enzymatic glycosylation and chemical diversification strategy.
    Thayer DA, Wong CH.
    Chem Asian J; 2006 Sep 18; 1(3):445-52. PubMed ID: 17441081
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
    Lohray BB, Lohray VB, Srivastava BK, Kapadnis PB, Pandya P.
    Bioorg Med Chem; 2004 Sep 01; 12(17):4557-64. PubMed ID: 15358283
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.